Document:

Exhibit 10.14

 

INTEC PHARMA LTD.

 

EMPLOYMENT AGREEMENT

 

With Nadav Navon

 

AGREEMENT entered into as of
   between Nadav Navon, residing at 7 Socholovsky Zvi St., Rechovot, Israel (the “Employee”),
and Intec Pharma Ltd., an Israeli company with offices located at 10 Hertom St. Har Ha’hozvim, Jerusalem, Israel
(the “Company”).

 

WITNESSETH:

 

WHEREAS, the Company is in the
business of drug delivery gastric retentive platform (the “Business”); and

 

WHEREAS, the Company desires to employ Employee, and
the Employee desires to be employed  in the Company as Analytical Lab Manager.

 

NOW THEREFORE, in consideration of the premises and
mutual agreements hereinafter contained, the parties hereto agree as follows:

 

	1.	Contents
of Agreements/Definitions

 

The preamble and the exhibits to this
agreement (the “Agreement”) constitute an integral part hereof and are hereby incorporated by reference.

 

	2.	Employment
and Duties

 

2.1           As
of the Effective Date (as defined in Section 3 hereto), the Company employs Employee and Employee accepts employment with the
Company as Analytical Lab Manager upon the terms and conditions set forth herein (the “Position”). The Employee
shall report regularly to the Company’s VP R&D, and/or to any other officer of the Company, under the Company’s sole discretion.
Notwithstanding the above, the Company may change the Employee’s Position as it may deem fit and such action shall not be considered
a material adverse change in the Employee’s employment conditions.

 

2.2           Employee
shall devote all necessary time and attention to the Business of the Company and shall perform his duties diligently and
promptly for the benefit of the Company.

 

2.3           Employee
shall work five days a week, Sunday to Thursday, unless otherwise required by the Company, upon its sole discretion.

 

2.4           During
his engagement hereunder, Employee shall not, without the prior written consent of the Company, undertake or accept any
other paid or unpaid employment or occupation or engage in or be associated with (other than through an investment in a
corporation which is financial in its nature and in which Employee holds less than 5% of the  outstanding shares), directly
or indirectly, any other businesses, duties or pursuits except for de minimis non-commercial or non-business
activities.

 

	3.	Term
and Termination of Employment

 

3.1        Employee’s
employment under this Agreement shall commence on    6 (the “Effective Date”) and shall end on the earliest of
(i) the death or disability (as defined herein) of Employee; (ii) termination by either party.

 

    	 

    	 

    

 

3.2           Either
party may terminate this Agreement without cause, as hereinafter defined, by providing thirty (30) days prior written notice (the
“Notice Period”). During the Notice Period Employee shall continue his services unless otherwise instructed,
and shall cooperate with the Company and use his best efforts to assist the integration into the Company organization of the person
or persons who will assume the Employee’s responsibilities. Notwithstanding the above, during a period of 3 months following the
Effective Date (the: “Trail Period”), the Notice Period shall be fourteen (14) days.

 

3.3           At
any time, the Company shall be entitled to immediately terminate Employee’s employment hereunder for ‘cause’ (as set forth in
Section 4.1 below) by providing notice thereof to Employee.

 

	4.	Provisions
Concerning the Term of Employment

 

4.1           For
the purpose of this Agreement, “cause” shall exist if Employee (i) breaches any of the terms of Sections 2.1, 7, 8,
9 and 10 or; (ii) engages in willful misconduct or acts in bad faith with respect to the Company in connection with and related
to the employment hereunder; (iii) is convicted of a felony or is held liable by a court of competent jurisdiction for fraud against
the Company; (iv) fails to reasonably comply with the instructions of the Company given to the Employee in good faith and relating
to the performance of Employee’s duties under his Position; or (v) is dismissed under the circumstances defined in Section 16
and/or Section 17 of the Severance Pay Law, 1963 (hereinafter: “The Severance Pay Law”); provided that, with
respect to clauses (i) and (iv), if Employee has cured any such condition (that is reasonably susceptible to cure) within 10 business
days (“Grace Period”) of the advance notice (as defined herein), then “cause” shall be deemed not
to exist. For purposes of this Section 4, “advance notice” shall constitute a written notice delivered to Employee
that sets forth with particularity the facts and circumstances relied on by the Company as the basis for cause.

 

4.2           For
the purposes of this Agreement “disability” shall mean any physical or mental illness or injury as a
result of which Employee remains absent from work for a period of two (2) successive months, or an aggregate of two (2)
months in  any twelve month period. Disability shall occur upon the end of such two (2) month period.

 

	5.	Compensation

 

		5.1	5.1.1 During the
                                         term hereof, and subject to the performance of the services required to be performed hereunder
                                         by Employee, the Company shall pay to Employee for all services rendered by Employee
                                         under this Agreement, a salary, payable not less often than monthly and in accordance with
                                         the Company’s normal and reasonable payroll practices, a monthly gross amount equal to
                                         NIS 22,000 (the “Gross Salary”). Notwithstanding the above, during the
                                         Trial period, the Gross Salary shall be equal to NIS 20,000.

 

		 	5.1.2     An
                                         amount equal to 10% of the Gross Salary of the Employee, shall be considered as a special
                                         compensation for the Employee’s obligation not to compete with the Company, as defined
                                         in Section 8 herein (hereinafter: “The Special Compensation”).

 

			5.1.3    
                                         The Company will pay the Employee the Gross Salary until the 9th of each month,
                                         for the previous month.

 

			5.1.4     In addition, in accordance with the
                                                                            Company’s policy, once a year the parties will
                                                                            conduct a salary review for the Employee, during which the Company shall evaluate the Employee’s performance and shall
                                                                            decide                                                                                      (according to the performance of
                                                                            the Employee and the development of the Company) whether to increase his salary, and, if so,
                                                                            in what amount. Nothing in this clause shall be construed as the Company’s commitment to increase the Employee’s salary
                                                                            at any                                                                                      time.

 

    	-2-

    	 

    

 

5.2           Insurance
Policy: The Company and the Employee will obtain and maintain an insurance policy for the exclusive benefit of the Employee,
as follows: The Company shall continue to insure the Employee under his existing pension fund (the “Keren
Pensia”), under which the Company shall contribute 6% of an amount equal to 2 (two) times the average wage in
Israel (the “Maximum Amount”) as compensatory payments, and 8.33% of the Maximum Amount in lieu of
severance pay (i.e. 6% of the Maximum Amount to the Keren Pensia + an additional 2.33% of the Maximum Amount towards a
‘Kupat Gemel’). The Employee shall contribute in respect of such Keren Pensia a monthly amount equal to five and
one half percent (5.5%) of the Maximum Amount.

 

In addition, the Company shall obtain
and maintain a manager’s insurance policy for the exclusive benefit of the Employee in the customary form with respect to
which the Company shall be the beneficiary (the “Bituach Menahalim”). The Company shall contribute to such
Bituach Menahalim a monthly amount equal to thirteen and one third percent (13.33%) of an amount equal to the difference between
the Maximum Amount and the Gross Salary (the “Exceeding Amount”), out of which 8.33% are designated for severance
payments and 5% are designated for compensatory payments. The Employee shall contribute in respect of such Bituach Menahalim a
monthly amount equal to five percent (5%) of the Exceeding Amount as compensatory payments. The Employee hereby instructs the
Company to transfer to the Keren Pusia and the Bituach Menahalim all amounts on account of both the Company’s and Employee’s
Contributions in respect of such plans.

 

5.3           It
is hereby agreed that upon termination of employment under this Agreement, the Company shall release to the Employee all
amounts accrued in the Keren Pencia and the Bituach Menahalim on account of both the Company’s and Employee’s
Contributions. It is hereby agreed that if the Employee is dismissed under the circumstances defined in Section 16 and/or
Section 17 of the Severance Pay Law - the Employee shall not be entitled to any Severance Pay.

 

It is hereby clearly agreed and
understood that the amounts accrued in the Keren Pensia and the Bituach Menahalim on account of the Company’s
Contribution shall be in lieu and in full and final substitution of any severance pay the Employee shall be or become
entitled to under any applicable Israeli law. This section is in accordance with Section 14 of the Severance Pay Law, and the
General Approval of the Labor Minister, dated June 30, 1998, issued in accordance to the said Section 14, a copy of which is
attached hereby as Appendix A

 

5.4          In addition, the Company shall
obtain Disability Insurance (“Ovdan Kosher Avoda”), which may be included within the Bituach Menahalim, for
the exclusive benefit of the Employee and shall contribute therefore an amount not exceeding two and a half percent (2.5%) of
each monthly Gross Salary Payment, or such amount required to enable the payment of at least 75% of the Gross Salary.

 

5.5
      The Company and the Employee shall open and maintain a Keren Hishtalmut Fund for the
exclusive benefit of the employee (the “Fund”). The Company shall contribute to such Fund an amount equal
to seven and a half percent (7.5%) and the Employee shall contribute to such Fund an amount equal to two and a half percent
(2.5%) of each monthly Gross Salary payment. The Employee hereby instructs the Company to transfer to the Fund the amount of
the Employee’s and the Company’s contribution from each monthly Gross Salary payment.

 

For the removal of doubt it is hereby clarified,
that is the event of termination of Employee’s employment under this Agreement for any reason other than a termination for cause
(as defined above) Employee shall be entitled to all sums accumulated in the Fund. In the event of termination for cause (as defined
above) Employee shall not be entitled to any of Company’s contributions to the Fund made during this Agreement.

 

    	-3-

    	 

    

  

5.6           The
Employe will be entitled to use a leased company car (the: “Company Car”), The Company  Car type shall be
of Reno-Megan (group 2). The Company will cover all the operating expenses of the Company Car (excluding parking expenses
and/or fines), and the Employee shall bare any and all taxes applicable to Employee in connection with the Company Car.
Payments of the Company Car’s expenses by the Company under this paragraph are in lieu of traveling expenses to and from work
as required by the Extension Order.

 

Employee shall take good care of such Company Car and
ensure that the provisions of the insurance Policy and Company’s rules relating to Company Car are strictly, lawfully and
carefully observed. Employee is aware that in order to provide Employee with the Company Car the Company shall lease the
Company Car from a leasing company, and Employee undertakes to strictly comply with the provisions of the leasing
agreement.

 

Employee shall return Company Car
(together with its keys and any other equipment supplied and/or installed therein by Company) to Company’s principal office upon,
termination of Employee’s employment with Company. Employee shall have no rights of lien with respect to Company Car and/or any
other equipment relating thereto as above mentioned.

 

5.7           Company
shall provide Employee with, and pay for the use of, a cellular phone for Employee’s use in the course of
performing Employee’s obligations under Employee’s Position, up to an aggregate amount of NIS 300 per month (the
“Cellular Phone”). Employee shall bear any and all taxes applicable to Employee in connection with the Cellular
Phone and/or the use thereof. Employee shall return the Cellular Phone to Company’s principal office upon termination of
Employee’s employment with Company. Employee shall have no rights of lien with respect to the Cellular Phone.

 

5.8           Subject
to an adoption of an Employee stock option plan by the Company, Employee shall be granted options to purchase shares of the Company.
The option shall be subject to the terms of the Company’s Employee Stock Option Plan, and the option agreement to be entered into
between the Company and the Employee, following the adoption of  an Employee Stock Option Plan by the Company.

 

	5.9	The
    Agreed Alternative Payment - in Case_of a Claim for Overtime Payments

 

5.9.1           Employee
agrees and acknowledges that due to his position in the Company, the Hours of Work and Rest Law, 1951 (hereinafter:
“the Hours of Work and Rest Law”) does not apply on him. Therefore, the Employee shall not be entitled to
claim or receive payments or any additional pay for overtime working hours, shifts, or work performed on Saturday or
holidays.

 

5.9.2           The
Employee undertakes, by signing this Agreement, that he will not sue, and/or demand, and/or claim that he is entitled to any
additional payment to his Monthly Gross Salary due to overtime, above his Monthly Gross Salary which includes all the
consideration which the Employee is entitled to receive for overtime.

 

5.9.3           Therefore,
if notwithstanding the agreement of the parties and the Employee’s informed undertaking under this Agreement, it will be
decided by a competent court, or any other competent tribunal, either due to Employee’s application or any other source, that
the Hours of Work and Rest Law applies to the Employee, and that therefore the Employee is entitled to compensation, or any
other additional payments due to overtime –  then the parties hereto agree that the salary, which the Employee was
entitled to, was 75% (Seventy-five percent) of the Monthly Gross Salary which was paid to the Employee under this Agreement.
(hereinafter the “Agreed Alternative Payment”).

 

5.9.4           The
Employee will be obligated to return the Company, on the day of the claim and/or demand which contradicts this Agreement, in
which it will be claimed that the Working Hours and Rest Law applies to him, and/or that he was entitled to Overtime Payments
– all additional payments that the Employee received from the Company over the Agreed Alternative Payment as defined
above (the “Excess Amount”).

 

    	-4-

    	 

    

 

5.9.5      
Each Excess Amount that the Employee will be obligated to return to the Company as mentioned above - shall bear interest
and shall be linked to the Cost of Living Index on the  Employee’s pay day – as compared to the Index on the day
such amount will be returned to the Company.

 

5.9.6     
The Company shall be entitled to set off such Excess Amounts against all amounts that the Employee shall be entitled to under
this Agreement, or under the decision of the Court or of any other competent tribunal as mentioned above, which shall not
derogate from any other right of the Company to receive from the Employee the rest of the amounts it is entitled to.

 

	6.	Taxation

 

6.1           To
the extent applicable, the Company may deduct from the compensation payable to Employee under this Agreement any and
all taxes and charges (including health tax) applicable to Employee as may now be in effect or which may hereafter be enacted
or required by law, and make the appropriate payments on behalf of Employee to the income tax authorities, the Institute
of National Insurance and any other relevant authority. Employee shall respectively pay all  taxes and payments as required
or shall be required by any applicable law. Employee shall notify the Company of any change in Employee’s place of
residence or status, which may affect Employee’s tax liability anywhere in the world.

 

6.2          The
Employee acknowledges that some of the benefits granted to Employee under this Agreement may be treated by the authorities as
additional compensation to Employee, and therefore Employee agrees that, in such event Employee shall pay all taxes, national
insurance contributions, and other payments required to be paid to the authorities in connection therewith

 

	7.	Secrecy
    and Nondisclosure

 

7.1           The
Employee shall treat as secret and confidential all of the processes, methods, formulas, procedures, techniques, software,
designs, data, drawings and other information which are not of public knowledge or record pertaining to the Company’s
Business (existing, potential and future), including without limitation, all business information relating to customers and
suppliers and products of which the Employee becomes aware during and as a result of his employment or association with the
Company, and Employee shall not disclose, use, publish, or in any other manner reveal, directly or indirectly, at any time
during or after the term of this Agreement, any such processes, methods, formulas, procedures, techniques, software, designs,
data, drawings and other information pertaining to the Company’s existing or future Business or products The Employee may
disclose or use such information, if at all, only with the prior express written consent of the Company.

 

7.2           The
Employee hereby undertakes to return, upon request, to the Company, all written materials, records, documents, computer software
and/or hardware or any other material which belongs to the Company and that might be in his possession, and if requested by the
Company to do so, will execute a written statement confirming compliance with the above said.

 

7.3           The
Employee acknowledges that all of the secrets, information, or documents aforementioned in Sub-Sections 7.1 and 7.2 above, are
essential commercial and proprietary information of the Company which is not public information and cannot easily be discovered
by others, whose confidentiality provides the Company a commercial advantage over its competitors, and the Company is taking reasonable
measures to safeguard its confidentiality.

 

7.4          The Employee’s undertakings pursuant to this clause shall
remain in force after the termination of Employee’s employment under this Agreement.

 

    	-5-

    	 

    

  

		8.	Non - Competition

 

8.1          Employee
agrees that during the term of this Agreement and for a period of one (1) year after he ceases to be employed by the Company
he will not, directly or indirectly, for his own account or as an employee, officer, director, partner, joint venturer.
shareholder, investor, consultant or otherwise (except as an investor in a corporation whose stock is publicly traded and in
which Employee holds less than 5% of the outstanding shares) and without the prior written consent of the Company, interest
himself in or engage in any business or enterprise, anywhere in the world, that directly competes with the Business of the
Company, that exists now or in the future or is based on similar technology to the technology that was developed by the
Company.

 

8.2          Employee
agrees that during a period of six months from termination of this Agreement, he shall not employ directly or indirectly any individual
employed by the Company during the six-month period, which preceded such date of termination.

 

8.3          Employee
acknowledges that the restricted period of time and geographical area specified under Sections 8.1 and 8.2 hereof are reasonable,
in view of the nature of the business in which the Company is engaged and Employee’s knowledge of the Business.

 

8.4         Notwithstanding
anything contained in Section 8.3 to the contrary, if the period of time or the geographical area specified under Sections 8.1
or 8.2 hereof should be determined to be unreasonable in any judicial proceeding, then the period of time and area of the restriction
shall be reduced so that this Agreement maybe enforced in such area and during such period of time as shall be determined to be
reasonable by such judicial proceeding.

 

8.5          If
the Employee shall breach any of his obligations under this Section 8 - The Employee will be obligated to return the Company,
immediately, the Special Compensation, as defined above. Such Special Compensation thus returned to the Company:

 

8.5.1          Shall
bear interest, and shall be linked to the Cost of Living Index on the Employee’s pay day– as compared to the Index on
the day such amount will be returned to the Company.

 

8.5.2          Shall
not derogate from any other right of the Company to receive from the Employee the rest of the amount it is entitled to.

 

8.6          The
Employee declares and acknowledges that:

 

8.6.1          His
obligations of protecting the confidentiality and non-competition provisions included in this Agreement are fair, reasonable,
and proportional, especially in light of the special compensation he receives under this Agreement which is designed to protect
the Company’s secrets and its confidential information, which constitute the essence of its protected business and commercial
advantage in which significant capital investments were made.

 

8.62         Breach
of an obligation under this Section - shall contradict the nature of the special trust and relationship of loyalty between the
parties, the fair and proper business practices, the duty of good faith and fairness between the parties, shall harm the Company,
and shall constitute a material breach of this Agreement and the trade secrets, confidential connections, confidential information,
and other privileged interests of the Company.

 

8.6.3          The
Employee declares that his obligations under this section, which are reasonable and proportional - do not prevent the employee
from developing his general knowledge and professional expertise in the area of his business, with regard to those who are not
customers and employees of the Company and without usurping its trade secrets.

 

    	-6-

    	 

    

 

9.         Development
Rights

 

The Employee agrees and declares that, all proprietary
information including but not limited to copyrights, trade secrets and know-how, patents and other rights in connection
therewith developed by or with the contribution of Employee’s efforts during his employment by the Company shall be the sole
property of the Company, and the Employee shall execute all documents necessary to assign any patents to the Company and
otherwise transfer such proprietary rights to the Company. In Addition, Employee agrees to be bound by the terms and
conditions of the Intellectual Property assignment of rights stated in Appendix B hereto, incorporated by
reference as part of this Agreement.

 

10.         Employee
Representations and Acknowledgments

 

The Employee represents and
warrants to the Company that the execution and delivery of this Agreement and the fulfillment of the terms hereof (i) will
not constitute a default under or breach of any agreement or other instrument to which he is a party or by which he is
bound, including without limitation, any confidentiality or non-competition agreement, (ii) do not require the consent of any
person or entity, and (iii) shall not utilize during the term of his employment any proprietary information of any third
party, including prior employers of the Employee.

 

11.         Vacation,
Illness, Dmey Havra’ah

 

11.1         Employee
shall be entitled to such number of paid vacation days during each year of his employment, as provided by Israeli Labor Law.

 

11.2         Employee
shall be entitled to such number of working days of paid illness vacation during each year of his employment, as provided by Israeli
Labor Law, or more, in accordance with Company Policy.

 

11.3         The
employee shall be entitled to “Dmey Havra’ah”in accordance with any applicable law.

 

12.         Benefit

 

Except as otherwise
herein expressly Provided, this Agreement shall inure to the benefit of and be binding upon the Company, its successors and assigns,
including, without limitation, any subsidiary or affiliated entity and shall inure to the benefit of, and be binding upon, Employee,
his heirs, executors, administrators and legal representatives, Notwithstanding the foregoing, the obligations of Employee hereunder
shall not be assignable or delegable.

 

13.         Entire
Agreement

 

This Agreement constitutes the entire understanding and agreement
between the parties hereto, supersedes any and all prior discussions, agreements and correspondence with regard to the subject matter
hereof, and may not be amended, modified or supplemented in any respect, except by a subsequent writing executed by both parties
hereto.

 

14.         Notices

 

All notices, requests and other communications
to any party hereunder shall be given or made in writing and telecopied, mailed (by registered or certified mail) or delivered
by hand to the respective party at the address set forth in the caption of this
Agreement or to such other address (or telecopier number) as such party may hereafter specify for the purpose of notice
to the other party hereto. Each such notice, request or other communication shall be effective (i) if given by facsimile,
when such facsimile is transmitted to the facsimile number specified herein and the appropriate answerback is received or (ii)
if given by any other means, when delivered at the address specified herein.

 

    	-7-

    	 

    

 

15.         Affiliated
Companies

 

For the purpose of Sections 7 and 8 above, the term “Company” shall
include also the Company’s Parent company, Company’s subsidiary or any company controlled or owned by the Company’s parent
company.

 

		16.	Applicable Law

 

16 .1         This
Agreement shall not derogate from any Applicable Law, Extension Order, or Collective Agreement.

 

16.2         This
Agreement shall be governed by, and construed and enforced in accordance with, the laws of Israel without giving effect to principles
of conflicts of law and the courts of Israel, District of Tel Aviv, shall have exclusive jurisdiction over the parties hereto and subject
matter hereof.

 

IN WITNESS WHEREOF, the parties
have executed this Agreement as of the date first appearing above.

 

	/s/ Efi Cohen Arazi	 	/s/ Nadav Navon
	INTEC PHARMA LTD.	 	EMPLOYEE

 

    	-8-

    	 

    

 

 

APPENDIX A

 

General Approval (Combined Version) Regarding
Employers’ Contributions to 

Pension Funds and
Insurance Funds in lieu of Severance Pay

Under the Severance Pay Law, 5723-1963

[Updated as of February 28, 2001]

 

By virtue of my power under Section 14
of the Severance Pay Law, 5723-19631 (the “Law”), I hereby confirm, that contributions made by an employer
for his employee, commencing as of the date of publication of this approval, to a comprehensive pension in a provident fund for
annuity that is not an insurance fund within the meaning of such term in the Income Tax Regulations (Rules for the Approval and
Management of Provident Funds), 5724-19642 (a “Pension Fund”) or to a managers’ insurance that includes
the possibility of an annuity or a combination of payments to an annuity plan and to a non-annuity plan within such insurance fund
(an “Insurance Fund), including combined contributions made by the employer to a Pension Fund and to an Insurance Fund, whether
or not the Insurance Fund includes an annuity plan (the “Employer's Contributions”), shall be payable in lieu of severance
pay due to such employee in respect of the salary from which such contributions were made and the period they were made for (the
“Exempt Salary”); provided, however, that all of the following conditions have been fulfilled:

 

		(1)	The Employer's Contributions -

 

		(a)	To the Pension Fund, are at a rate of no less than 14 1/3% of the Exempt Salary, or 12% of the
Exempt Salary, if in addition thereto, the employer makes supplementary severance pay contributions for his employee to a provident
fund for severance pay or to an Insurance Fund in the employee's name, at a rate of 2 1/3% of the Exempt Salary. In the event that
the employer has not contributed such 2 1/3% in addition to said 12%, his contributions shall only replace 72% of the employee's
severance pay;

 

		(b)	To the Insurance Fund are at a rate of no less than one of the following:

 

		(1)	13 1/3% of the Exempt Salary, if in addition thereto, the employer makes contributions for his
employee for securing monthly income in the event of disability to a plan approved by the Commissioner of the Capital Market, Insurance
and Savings at the Ministry of Finance, at the rate required to secure at least 75% of the Exempt Salary or a rate of 2 1/2% of
the Exempt Salary, whichever is lower (“Disability Insurance Contributions”); or

 

 

		1	Statues 5723, p. 136.

		2	Regulations 5724, p. 1302.

 

    	-9-

    	 

    

 

		(2)	11% of the Exempt Salary, if the employer also made Disability Insurance Contributions, and in
such case the Employer's Contributions shall only replace 72% of the Employee's severance pay; In the event that the employer has
made, in addition to the foregoing, supplementary severance pay contributions to a provident fund for severance pay or to an Insurance
Fund in the employee's name at a rate of 2 1/3% of the Exempt Salary, the Employer's Contributions shall replace 100% of the employee's
severance pay.

 

		(2)	By no later than three months of the commencement date of the Employer's Contributions, a written
agreement is executed between the employer and the employee that includes:

 

		(a)	The employee’s consent to the arrangement pursuant to this approval in a form specifying
the Employer's Contributions, and the Pension Fund and Insurance Fund, as applicable; such agreement shall also include the form
of this approval;

 

		(b)3	The employer’s advance waiver of any right he may
have to a refund of monies from his contributions, unless the employee’s right to severance pay has been revoked by virtue
of Sections 16 or 17 of the Law, and to the extent so revoked, or the employee has withdrawn monies from the Pension Fund or Insurance
Fund other than by reason of an Entitling Event; in such regard "Entitling Event" means death, disability or retirement
at or after the age of 60 or more

 

		(c)	This approval shall not derogate from the employee's right to severance pay under any law, collective
agreement, expansion order or employment contract, in respect of salary over and above the Exempt Salary.

 

	 	Eliyahu Yishai
	 	 
	 	Minister of Labor and Social
	 	Affairs

 

Signature of employee:

 

	 	 	 	 	[signature]	 
	 	 	 	 	 	 
	Date: 	 	 	Signature: 	/s/ Nadav Navon	 

 

 

		3	Amendment: Official Gazette 4803, 5760 (September 19, 1999).

 

    	-10-

    	 

    

 

APPENDIX
B 

 

Intellectual Property assignments
of rights

 

1.         For
purposes of this Appendix, the following definitions shall apply:

 

“Inventions”
shall mean:

 

A.          All
inventions, improvements, modifications, and enhancements whether or not patentable, made by the Employee during or in the
course of employment, or which relate, directly or indirectly to the business of the Company, or which were made using the
Company’ equipment, and

 

B.          All
inventions, improvements, modifications and enhancements made by the Employee, during a period of twelve (12) months (or such
lesser maximum period permitted by law) after any termination of the Employee’s employment, which relate, directly or indirectly,
to the business of the Company at the time they were so made.

 

“Work
Product” shall mean all documentation, software, hardware, firmware, creative works, artworks, know-how and information
created, in whole or in part, by the Employee during the Employee’s employment by the Company, whether or not copyrightable or otherwise
protectable, excluding Inventions.

 

“Trade
Secrets” shall mean “Commercial Secrets” as defined in the Law of Commercial Wrongs, 1999,
and all documentation, software, hardware, firmware, customer lists, know-how and other information of any kind or nature relating
to the past, present or future business of the Company or any plans therefor, or relating to the past, present or future business
of a third party or plans therefor (including but not limited to any items and information in any form determined by law as trade
secrets) that are disclosed to the Employee, which the Company does not disclose to third parties without restrictions on use
or further disclosure.

 

2.         Without
derogating from any other provision of the law:

 

A.          The
Employee shall promptly disclose to the Company all Inventions and keep accurate records relating to the conception and
reduction to practice of all Inventions. Such records shall be the sole and exclusive property of the Company, and the Employee
shall surrender possession of such records to the Company upon any termination of the Employee’s relationship with the
Company.

 

B.          The
Employee hereby assigns to the Company, without additional consideration to the Employee, the entire right, title and interest in
and to the Inventions and Work Product and in and to all proprietary and any and all intellectual property rights therein or based
thereon. The Employee shall execute all such assignments, oaths, declarations and other documents as may be prepared by the Company
to effect the foregoing.

 

C.          During
the term of this Agreement, and thereafter, the Employee shall provide the Company with all information, documentation, and
assistance the Company may reasonably request to perfect, enforce, or defend its proprietary rights in or based on the
Inventions, Work Product and/or Trade Secrets. The Company, in its sole discretion, shall determine the extent of the proprietary
rights, if any, to be protected in or based on the Inventions and/or Work Product. All such information, documentation, and
assistance shall be provided to the Company by the Employee at no additional expense to the Company, except for out-of-pocket
expenses which the Employee incurred at the Company’s request.

 

    	-11-

    	 

    

  

D.          During
the term of this Agreement, and thereafter, the Employee shall treat Inventions and Work Product as Confidential Information
under this Agreement and shall not disclose them to others without the prior written permission of the Company, or use such
Inventions and/or Work Product for any purpose, other than for the performance of services for the Company.

 

3.         Remedies.         The
Employee acknowledges that a breach of the covenants contained in this Agreement and this Appendix B would result in
substantial injury and damage to the Company for which there is no adequate remedy at law. Therefore, in the event of an actual
or threatened breach of such covenants by the Employee, the Company shall be entitled, in addition to all other rights,
remedies and damages that may be available to the Company at law or in equity, to a preliminary restraining order and an
injunction, or any other available equitable remedy, to restrain the violation or attempted violation of this Agreement by
the Employee or by any other person or entity acting for his benefit or on his behalf. In the event there is any action to
enforce the terms of such restrictive covenants, the prevailing party, in addition to any other remedy, shall be entitled to
recover reasonable attorney’s fees and all other reasonable costs associated with any such action both on the trial and
appellate level and in any creditor’s proceedings. In the event that a court of competent jurisdiction determines by
final non-appealable judgment that the scope, time period, or geographical limitations of any of the restrictive
covenants specifically set forth herein are too broad to be capable of enforcement, said court is authorized, and the parties
hereto stipulate that such court shall, modify said restrictive covenants and enforce such provisions as to scope, time, and
geographical areas as the court deems equitable, just and appropriate considering the intent of the parties hereto.

 

    	-12-

    	 

    

 

Translated from Hebrew

 

Annex to Employment Agreement

Entered into and signed in Jerusalem on May
29, 2011

 

	Between:	Intec Pharma Ltd., Company 513022780
	 	of 12 Hartom Street, Jerusalem
	 	(the "Company")
	 	of the first part;
	 	 
	And:	Nadav Navon
	 	of 7 Sochovolsky Street, Rehovot
	 	(the "Employee")
	 	of the second part;

 

		Whereas	the Employee serves as the Company’s R&D Manager under an employment agreement dated
January 15, 2006, which is attached hereto, with the annexes thereto, as Annex A (the “Agreement”);
and

 

		Whereas	the parties’ intention in respect of this document is to amend the terms and conditions of
the Agreement as specified below;

 

Wherefore the parties have represented,
stipulated and agreed as follows:

 

		1.	The preamble to this annex and the annexes hereto constitute an integral part hereof.

 

		2.	All of the rights and obligations specified in the Agreement shall continue to remain in force
and effect and all of the terms and conditions of the Agreement shall continue to apply between the parties, other than if and
insofar as expressly modified in this annex to the Agreement.

 

		3.	The following vesting conditions, shall apply, subject to receipt of the approvals required under
any law, to the options granted to the Employee on October 13, 2010,:

 

		a)	In events in which the Company is sold to a third party and/or control is transferred from the
present shareholders of the Company to a third party and/or its main assets are sold to a third party and/or the Company’s
business is merged with another company (including a “reverse acquisition” in which the shareholders of the Company
hold the majority of shares of the merged company) and/or a license is granted in respect of all of the Company’s assets
or its main assets and/or transactions the nature of which is like the transactions specified above (the “Acquisition
Event”), then – the vesting dates will be accelerated such that the Employee may exercise, immediately and upon
occurrence of the Acquisition Event, all of the options allotted to him, even if such options shall not have vested yet under the
terms of the Agreement.

 

    	 

    	 

    

 

		b)	Insofar as the Employee is dismissed for a reason that is not included in Section 4.1 of the Agreement,
the vesting dates of a relative part of the options allotted to him will be accelerated, even if the same have not yet vested.
The relative part will be calculated as the ratio between the number of days between the granting date and the dismissal date and
the time between the granting date and the original vesting date.

 

		4.	In addition to the salary specified in the Agreement, the Employee shall be entitled to receive
a bonus from the Company, in respect of engagement in a Commercialization Agreement, subject to the following conditions:

 

		a.	The Employee is employed by the Company on the date of signing of the Commercialization Agreement
and on the date of performance thereof, as defined hereunder.

 

		b.	The Company signs a Commercialization Agreement with a third party in respect of at least one of
its products.

 

In this annex, a “Commercialization
Agreement” is an agreement, engagement in which shall have been lawfully approved by the appropriate organs of the Company
under any law, and for the signing and consummation of which the Company receives monetary compensation, the net aggregate sum
of which, during the Employee’s term of employment with the Company, shall be no lesser than U.S. $10,000,000 (ten million
U.S. dollars).

 

		c.	The bonus rate shall be 1.5% of the consideration actually received by the Company up to an aggregate
amount received by the Company of U.S. $66.7 million.

 

It is clarified that the Employee
shall not be entitled to an additional bonus in respect of amounts exceeding U.S. $66.7 million which are paid, if and insofar
as they are paid, to the Company.

 

The aforesaid relative rate shall
be paid to the Employee on a current basis within 60 days of the date of actual receipt of the amounts by the Company.

 

		d.	For the avoidance of doubt, insofar as the Employee discontinues his employment with the Company
for any reason whatsoever, the Company shall not be obligated to pay any part of the bonus in respect of payments received subsequently
to the termination of the Employee’s employment with the Company.

 

		e.	The Employee shall exclusively bear payment of any tax deriving from receipt of the bonus under
applicable law. Payment of such tax shall be withheld by the Company, unless the Employee provides a certificate of exemption from
tax withholding.

 

		f.	The amount of the bonus, its rate, the manner in which it is determined and the payment date thereof
shall be exclusively determined by the Company, as per its sole and absolute discretion.

 

    	 

    	 

    

 

		g.	The Employee agrees that any claim, suit or demand stemming from the bonus or bonuses described
above shall be examined, insofar as the Company consents to such examination request, by a certified accountant, who shall be appointed
by the Company per the Company’s sole and absolute discretion, and the results of his examination shall be final and conclusive.
The Employee shall bear the full fee of the accountant, if the examination is conducted as per his request.

 

In witness whereof the parties
have hereunto set their hands

 

	/s/
    Giora Carni	 	/s/
    Nadav Navon
	Intec Pharma Ltd.	 	Nadav Navon

 

    	 

    	 

    

 

Translated from Hebrew

 

Addendum to Employment Agreement

Entered into and signed in Jerusalem on March
__, 2012

 

	Between:	Intec Pharma Ltd., Company 513022780
	 	of 12 Hartom Street, Jerusalem
	 	(the "Company")
	 	of the first part;
	 	 
	And:	Nadav Navon 24009011, I.D. 022152177
	 	of 7 Sochovolsky Street, Rehovot
	 	(the "Employee")
	 	of the second part;

 

		Whereas	the Employee serves as manager of the R&D Department under an employment agreement dated January
15, 2006, which is attached hereto, the annexes thereto, as Annex A (the “Agreement”); and

 

		Whereas	the parties intend for all of the rights granted to the Employee under the Agreement to remain
in force and effect and for all of the terms and conditions of the Agreement to continue to apply between the parties, other than
if and insofar as expressly modified in this annex;

 

Wherefore the parties have represented,
stipulated and agreed as follows:

 

		1.	The preamble to this addendum and the annexes hereto constitute an integral part hereof.

 

		2.	The monthly salary of the VP R&D shall be updated to NIS 37,000 per month as of March 1, 2012.

 

		3.	Section 7.4 of the Agreement shall be replaced with the following language:

 

“Each party may terminate this
agreement at any time by a written prior notice of 90 days to the other party”.

 

		4.	All of the other provisions of the Agreement shall remain in force and effect.

 

In witness whereof the parties have hereunto
set their hands

 

	/s/ Giora Carni	 	/s/ Nadav Navon
	Intec Pharma Ltd.	 	Nadav Navon

 

    	 

    	 

    

 

Translated from Hebrew

 

Amendment to Agreement

Entered into and signed in Jerusalem on October
21, 2013

 

	Between:	Intec Pharma Ltd., Company 513022780
	 	of 12 Hartom Street, Jerusalem
	 	(the "Company")
	 	of the first part;
	 	 
	And:	Nadav Navon, I.D. 24009011
	 	of 20 Eliezer Ben Yehuda Street, Rehovot
	 	("VP R&D & Operations")
	 	of the second part;

 

		Whereas	Mr. Nadav Navon serves as the Company’s VP R&D & Operations under an employment agreement
dated March 28, 2012, which is an update of the previous employment agreement (the “March 2012 Update”) of May
29, 2011 (the “May 2011 Update”), which is an update of his previous employment agreement with the Company dated
January 15, 2006 (the “January 2006 Agreement”); and

 

		Whereas	the parties intend to amend the January 2006 Agreement and the May 2011 Update and the March 2012
Update, as approved by the Company’s compensation committee and board of directors, all as specified in this amendment to
the agreement and subject to approval by the Company’s shareholders;

 

Wherefore the parties have represented,
stipulated and agreed as follows:

 

		1.	General

 

		1.1.	The preamble to this amendment to the agreement and the annexes hereto constitute an integral part
hereof.

 

		1.2.	The headings in this amendment to the agreement are added solely for the sake of convenience and
no use shall be made thereof for interpretation purposes.

 

		2.	Salary and Social Benefits

 

Update of gross monthly salary:
the monthly salary shall increase and amount to NIS 44,000.

 

		3.	Cash Bonus

 

The cash bonus of $1,000,000, to
which the VP R&D & Operations would be entitled due to the execution of a material agreement, is cancelled.

 

    	 

    	 

    

 

		4.	Options

 

		(1)	The VP R&D & Operations will be allotted 500,000 options for the purchase of 500,000 Company
shares of par value NIS 0.0.1 each, against an exercise price equal to the average of the share’s closing prices in the 30-day
period preceding the board of directors’ resolution. Options that shall vest over time shall become exercisable according
to the terms and conditions of the Option Plan. Options that shall vest over time shall be effective for a period of up to 72 calendar
months as of the granting date thereof. Options that shall vest over time shall expire at the end of 90 days as of the date of
termination of employment of the VP R&D & Operations, and shall be deemed null and void and non-exercisable, if, by such
time, entitlement to exercise the same shall not have arisen and the same shall not have been exercised by the VP R&D &
Operations;

 

		(2)	The VP R&D & Operations will be allotted, on a one-time basis, 2,860,000 contingent options
for the purchase of 2,860,000 Company shares of par value NIS 0.0.1 each, against an exercise price equal to the average of the
share’s closing prices in the 30-day period preceding the board of directors’ resolution on the allotment (the “Contingent
Options”). The Contingent Options are in keeping with the provisions of the Company’s Option Plan for Employees,
Officers, Directors and Consultants of 2005. The Contingent Options shall fully vest and be available for exercise immediately
after a Material Agreement becomes effective.

 

For this purpose, a “Material
Agreement” shall mean an agreement satisfying the following cumulative conditions: (a) an agreement shall have been signed
with a company or an entity, (b) in a transaction with the Company (or with another entity designated by the Company for the purpose
of such engagement) in connection with the Company’s core business, (c) the agreement shall have been approved by a majority
of the votes of the Company’s board of directors as a material agreement for the Company, and (d) the agreement significantly
increases the Company’s value for a reasonable duration of time.

 

The Contingent Options shall remain
in force and effect for a period of up to 72 calendar months as of the granting date thereof. The Contingent Options shall expire
at the end of 90 days as of the date of termination of employment of the VP R&D & Operations, and shall be deemed null
and void and non-exercisable, if, by such time, entitlement to exercise the same shall not have arisen and the same shall not have
been exercised by the VP R&D & Operations.

 

		5.	Termination of engagement

 

The Company and the VP R&D &
Operations may terminate the employment agreement by a written prior notice of 3 months.

 

    	2

    	 

    

 

		6.	Miscellaneous

 

		6.1.	All of the terms and conditions of the January 2006 Agreement and the May 2011 Update and the March
2012 Update, unless specifically amended in this amendment to the agreement, shall remain in force and effect and shall bind the
parties.

 

		6.2.	This amendment to the agreement shall be deemed, for all intents and purposes, as an integral part
of the January 2006 Agreement and the May 2011 Update and the March 2012 Update, and they shall constitute the full agreement of
the parties to the agreement in respect of the subject-matter at hand, which prevails over any and all previous agreements and
undertakings, both written and oral, between the parties to the agreement in respect of the subject-matter at hand.

 

In witness whereof the parties have hereunto
set their hands

 

	/s/ Giora Carni	 	/s/ Nadav Navon
	Intec Pharma Ltd.	 	Nadav Navon

 

    	3Exhibit 10.15

 

Employment Agreement

 

Entered into and executed in Jerusalem on
December 31, 2014

 

Between

 

Intec Pharma Ltd., Public Company 513022780

of 12 Hartom St., P.O. Box 45219

Jerusalem 91450

 

(the "Company")

 

of the first part

 

And

 

Name of Employee: Oren Mohar

I.D.: 028051282

Address: 84 Gia, Moshav Gia

 

(the "Employee")

 

of the second part

 

		Whereas	The Company has expressed its will to employ the Employee and the Employee has expressed his will
to be employed by the Company in the office of a Chief Financial Officer (the "Office"), and under the other terms
specified in this Agreement below; and

 

		Whereas	The Employee declares that he has the ability, qualifications, skills and experience required for
the fulfillment of the Office in which he will serve in the Company; and

 

		Whereas	The Employee will be exposed to knowledge and information pertaining to the Company or related
thereto, to the property, business and affairs thereof, the customers thereof, the suppliers thereof, the persons and entities
who have been or are in contact with the Company, including, but without derogating from the generality of the aforesaid –
methods, processes, prices, calculations, human resources management and setting compensation, conditions of agreements in which
the Company is engaged, and other documents of the Company; and

 

		Whereas	The Company and the Employee desire to regulate the terms of employment of the Employee, all as
specified in this Agreement below;

 

    	 

    	 

    

 

Now therefore, it had been declared, stipulated
and agreed between the parties as follows:

 

		1.	The Substance of the Agreement

 

		1.1.	This Agreement regulates the relations between the Company and the Employee, and exclusively determines
the terms of engagement of the Employee with the Company.

 

		1.2.	The headings of the clauses in this Agreement are for purposes of the parties' convenience only
and may not be used for interpretation of the Agreement or the terms hereof.

 

		2.	Employee’s Representations

 

The Employee represents to the Company
as follows:

 

		2.1.	He has the knowledge, ability, experience, qualifications and skills required for the performance
of the Office according to the provisions of this Agreement and the instructions of the Company from time to time.

 

		2.2.	He is not engaged in any other commitment or agreements which prevent him from being bound by this
Agreement, except for an advance notice period to his current employer.

 

		2.3.	He was neither indicted nor convicted of any criminal offense (apart from traffic offenses of no
moral turpitude), including an offense of moral turpitude, no criminal file was ever opened against him by the Israel police, and
to the best of his knowledge, no interrogation is currently being conducted against him.

 

		2.4.	He will keep in confidence all of the terms and details of this Agreement.

 

		2.5.	This Agreement is personal and specific, regulating the relations between the Company and the Employee
and exclusively sets forth the terms of employment of the Employee by the Company, and no non-mandatory law, nor any general and/or
specific collective bargaining agreements including the annexes related thereto, other agreements made from time to time between
employers and the General Federation of Labor or the New General Federation of Labor, nor agreements between the Company and any
other of its employees, shall apply to the Employee and the terms of his employment with the Company.

 

		2.6.	The Employee represents and warrants, that there is no restriction by an agreement or otherwise
against his engagement in this Agreement and/or against his employment with the Company pursuant to the terms of this Agreement,
and that he is entitled to engage in this Agreement and assume all of the obligations hereunder.

 

    	2

    	 

    

 

		3.	Employee's Undertakings

 

The Employee undertakes the following
towards the Company:

 

		3.1.	The Employee will be employed by the Company in a full time position as shall be required and according
to the instructions of the Company's management, in the position of a CFO (Chief Financial Officer).

 

		3.2.	The Employee represents that he is aware that his position at the Company is a position which requires
a special degree of personal trust, and undertakes that throughout his term of employment with the Company as aforesaid, he will
treat it with honesty, devotion, skill and loyalty and do everything in his power to promote the Company's goals and business and
safeguard its interests.

 

		3.3.	The Employee represents that he is not a party to any obligation or agreement contrary to the provisions
of this Agreement, including all implications thereof, including with his previous employers, and that within his employment with
the Company he will not use information contrary to the provisions of any agreement or undertaking.

 

		3.4.	Subject to the Company's requirements from time to time, the Employee undertakes to dedicate all
of the time and attention required, his qualifications, knowledge and experience for fulfillment of the Office solely for the Company's
benefit and interests. The Employee will have to be available to the Company to the extent required by the work conditions and
the needs of the Office.

 

		3.5.	That he will be reporting, within his Office, to the Company's CEO, and will comply with his instructions
pertaining to his work and/or Office, including but not limited to, instructions and/or directions regarding work procedures, carrying
out resolutions of the Company's board and any other instruction of the Company's CEO.

 

		3.6.	That he shall neither make any representation nor any statement nor shall he provide any undertaking
and/or consent and/or waiver and/or guarantee in the name of the Company nor will he impose any liability thereon, nor will he
use the name thereof, exceeding as necessary in his capacity as a CFO and the authorities conferred upon him according to this
Agreement and/or authorities which will be explicitly defined by the Company's management.

 

		3.7.	Not to engage in any other occupation, whether with another employer or independently, in any form
whatsoever, and/or fulfill any other office in any entity or in person, whether for or without compensation, directly or indirectly,
except for giving lectures provided that it does not interfere with the normal course of work, unless the Company's advance written
consent had been given thereto and subject to the terms of the consent, if granted. The Company may instruct the Employee at any
time, to cease the occupation in such issues, due to possible interference with the course of work, according to its discretion,
provided that it shall give the Employee advance notice thereof.

 

    	3

    	 

    

 

		3.8.	During the term of his employment and within the fulfillment of his Office, the Employee shall
act within the framework of the Company's procedures, discipline rules, articles of association and arrangements, as shall be determined
by the Company from time to time.

 

		3.9.	The Employee will not be entitled to receive, in relation to the performance of his Office, any
consideration or benefit, from any entity whatsoever, including customers or suppliers of the Company. Any amount and benefit,
or the equivalent thereof, which the Employee shall receive contrarily to the aforesaid, will belong to the Company and the Employee
undertakes to return them to the Company upon the first request.

 

		3.10.	To notify the Company immediately and with no delay of any issue in respect of which he has a personal
interest and/or which may create a conflict of interests with the Office.

 

		3.11.	The Employee undertakes, that during the term of his employment with the Company, and after termination
thereof, he will not assist any civil action which will be filed against the Company and/or entities related thereto, unless his
assistance is mandated by law, and he also undertakes to assist the Company, upon its request, in any reasonable manner, with any
claim and/or other proceeding in which the Company shall be involved. The aforesaid does not derogate from his rights as an employee
to demand and/or sue the Company regarding rights to which he will be entitled, if and to the extent he shall be so entitled.

 

		4.	Salary and benefits

 

		4.1.	During his term of employment, the Employee will be entitled to a monthly salary of NIS 45,000
gross (the "Monthly Salary"). The Monthly Salary will be linked to the Consumer Price Index known on the date
of execution of this Agreement and will be updated once every calendar quarter.

 

		4.2.	The Monthly Salary shall be paid to the Employee no later than the tenth day of each month, for
the preceding month, and after any amounts which the Company is obligated and/or entitled to deduct according to any law and/or
this Agreement, have been deducted.

 

		4.3.	The Company and the Employee will hold a compensation discussion for the updating of the Employee's
compensation once a year. In addition, the Company and the Employee will hold a discussion regarding performance based bonuses,
once a year, subject to the provisions of the Company's compensation policy.

 

    	4

    	 

    

 

		4.4.	Leave: The Employee will be entitled to 24 days of leave a year. The leave timing will be coordinated
by agreement between the parties. It is clarified that the Employee's leave days are accruable, such leave accrual not to exceed
twice the Employee's annual leave day quota. In the event that the Employee shall have reached the leave day ceiling and the Company
requests that he not take more leave, and the Employee therefore requests to redeem the additional leave days – then the
aforesaid additional leave days will be redeemed through the Employee's Salary.

 

		4.5.	Sick leave: The Employee will be entitled to a number of paid sick leave days a year as set forth
in the law, according to the Company's procedures. It is clarified that the Employee will be entitled to full payment for sick
leave days, from the first sick day, subject to the presentation of a medical certificate.

 

		4.6.	Recuperation pay: the Employee will be entitled to recuperation pay as set forth in the law, whereby
for the first year, the Employee is entitled to 7 recuperation days.

 

		4.7.	Severance pay: the Employee will be entitled to severance pay according to and subject to the provisions
set forth in any law.

 

		4.8.	It is agreed that the Company shall be entitled to deduct from the Salary and/or from any payment
which the Employee shall be able to receive from the Company, any amount which the Employee shall owe the Company, subject to a
decision of a judicial instance.

 

		4.9.	The provisions of Section 4.7 above constitute an instruction and undertaking according to the
Salary Protection Law, 5718-1958 as well.

 

		4.10.	Overtime: The Employee hereby represents that he knows and agrees that within the capacity of his
Office, which requires a special degree of personal trust and work during overtime, on the weekly rest day and during holidays,
he is not included in the employees to whom the Work and Rest Hours Law, 5711-1951 applies. Alternatively, and subject to
the actual performance of such overtime, the parties agree that the Monthly Salary includes payment for working overtime as mandated
by the Employee's Office and he will not be entitled to claim or receive any payments or additions due to his working overtime.

 

In any event which the Employee shall
sue the Company for work that he had worked during holiday and/or overtime, the gross Salary shall be retroactively reduced by
the claim amount, so that the entire amounts paid to the Employee for his work during a certain month will not exceed the Monthly
Salary.

 

    	5

    	 

    

 

		4.11.	Apart from the payments in respect of which the parties have explicitly agreed otherwise in writing,
then all of the payments of any type which the Employee shall receive from the Company, including the Salary and other benefits
and payments of any type whatsoever as specified in this Agreement, will be gross and the taxes, levies and national insurance
fees which must be deducted according to law, will be withheld therefrom.

 

		4.12.	During the term of his employment, the Employee will receive no payment or other benefit from any
third party who is in direct or indirect contact with the Company and/or who is related in any manner to the Employee's employment
with the Company. Breach of this provision will constitute a fundamental breach of the Agreement. In addition, and without derogating
from any other remedy, the amount and/or benefit received by the Employee will be attributed to the Company, and the Company will
be entitled to deduct this amount or the value of the benefit from any and all amounts due to the Employee therefrom.

 

		4.13.	It is clarified, for avoidance of any doubt, that the provisions of the Agreement hereinbefore
and hereinafter, are subject to the Company's current compensation policy, as published on the MAGNA and MAYA websites (the "Compensation
Policy").

 

		5.	Managers' Insurance, Study Fund, Other Benefits

 

		5.1.	During the period of application of this Agreement, and subject to directives which will be set
forth from time to time by the Income Tax Commission, the Company will contribute to the Employee's credit in respect of his full
Salary as specified in Section 4.1 above, to a managers' insurance or a pension fund, at a rate of 13.33% of the Employee's Salary,
out of which 5% for provident payments and 8.33% on account of severance pay, and 5% will be deducted from the Employee's salary
for provident payment and will be transferred to a managers' insurance plan or a pension fund. Amounts exceeding the ceilings set
from time to time by the Income Tax Commission, will be remitted while deducting tax or will be paid directly in the Employee's
Salary (at the Employee’s choice).

 

		5.2.	The Company will secure insurance for loss of working capacity, which may be included within the
insurance policy, to the benefit of the Employee, and will bear insurance at a rate not exceeding 2.5% of each payment of the gross
Monthly Salary, or the rate required for securing 75% of the gross Monthly Salary, whichever is lower.

 

		5.3.	The Company undertakes, commencing from the date of execution of this Agreement, to contribute
an amount in NIS which is equal to 7.5% of the Monthly Salary to a study fund, which will be paid directly to a study fund. The
Employee will deduct an additional amount which is equal to 2.5% of the Monthly Salary as aforesaid. The Employee hereby agrees
that the Company will deduct the said amount from his Salary. Amounts exceeding the ceilings set from time to time by the Income
Tax Commission will be remitted while deducting tax or will be paid directly in the Employee's Salary (at the Employee's choice).

 

    	6

    	 

    

 

		5.4.	It is hereby agreed that upon termination of employment according to this Agreement, the Company
will release to the Employee all of the amounts accrued in his name in the insurance policy, the pension fund and the study fund
and which were contributed from his Salary. In addition, the Company shall release to the Employee also all of the amounts which
were accrued in an insurance policy and which were contributed by the Company, except in the event of a fundamental breach of this
Agreement. The contributions on account of severance pay will be released, both in the event of dismissal or resignation of the
Employee, according to Section 14 of the Severance Pay Law.

 

		5.5.	For the avoidance of doubt, in the event that the Employee shall be dismissed under circumstances
which shall be ruled by a court as defined in Section 16 and/or Section 17 of the Severance Pay Law and/or in the event that the
work relations between the Employee and the Company shall be terminated under circumstances which shall be ruled by a court to
constitute a severe disciplinary violation, a fundamental breach of employment contract, betrayal of trust, an offense of moral
turpitude as well as upon the occurrence of the events specified in Section 7.4 below, he will not be entitled to severance pay
and advance notice.

 

		5.6.	It is hereby agreed, unequivocally that the amounts accrued in the insurance policy on account
of the Company's participation (i.e. 8.33% of any payment of a gross Monthly Salary) will be in lieu and as a final and
full substitution to any severance pay which the Employee will be or will become entitled to according to any law which shall apply.
This Section is according to Section 14 of the Severance Pay Law, 5723-1963, and the Approval of the Minister of Labor and Social
Affairs in an order dated June 30, 1998, which was given according to Section 14 as aforesaid, including the amendments thereto,
and which is attached to this Agreement as Annex B.

 

		5.7.	It is agreed that the provisions of Sections 4 and 5 above and in Section 6 below, exhausts all
of the Employee's entitlements from the Company for fulfilling his Office as provided in this Agreement and the Employee will have
no claim against the Company and/or any demand in addition to that.

 

		6.	Car and Cellular Phone

 

		6.1.	The Company shall provide the Employee with a private car of a car group approved for VP's rank
according to the Compensation Policy as of the date of this Agreement, or equivalent in value and cost, according to the Employee's
choice and will bear all of the expenses involved in the use of the car (licensing, insurance, repairs, deductible, toll road and
so forth) (the "Car") including the gross-up of the tax required by law. Replacing the Car with a new one shall
be done according to the Company's discretion. Alternatively, in the event that the Employee will decide in the future that he
is not interested in a Company car as aforesaid, he will receive in his Salary a monthly supplement ("Car Maintenance and
Travel") equivalent to the cost of the Car for the Company (including the cost of leasing and gross-up) as well as the
cost of the expenses for car maintenance as specified above. This supplement will be updated in the beginning of every year according
to the cost for the Company.

 

    	7

    	 

    

 

		6.2.	The Employee will ensure proper maintenance of the Car and will use the Car reasonably and with
care. The use and servicing of the Car will be according to the instructions and procedures of the Company as shall be in effect
from time to time.

 

		6.3.	The Employee represents that it has been made clear to him that he is personally responsible for
the payment of the deductible in case of an accident and/or theft of the car, in the event that it is proven, in the opinion of
the insurance company, that the same is the Employee’s fault, and he will also be responsible for the payment of any traffic
fines and/or parking tickets and/or other fines and reports, which will be imposed in respect of the Car in the name of the Company
or in the name of the Employee, all as shall be determined from time to time by the Company. If an employee does not act as specified
in this Section, the Company shall endorse the reports and/or fines as aforesaid in the Employee's name. For avoidance of doubt
it shall be clarified, that the Employee's liability according to the provisions of this Section will apply also if the fact of
the fines and/or reports in respect of the Car will become known to the Company after the Employee had left the Company, and that
if the Employee will not act as specified in this Section, the Company will endorse the fines and/or reports as aforesaid, to the
name of the Employee.

 

		6.4.	In the event that the Employee shall elect to appeal against or be trialed in respect of fines,
the Employee will bear any payment imposed on him. In addition, the Employee may negotiate with the leasing company, in order to
try and reduce the payment amount. In the event that the Employee did not reach any agreements with the leasing company within
reasonable time, and will fail to pay the deductible as specified in Section 6.3 above and/or the fines as aforesaid, the Company
will be entitled to pay the amount of the deductible and/or the amounts of the fines and the Employee hereby gives the Company
an irrevocable instruction to deduct such amounts from any amount which he will be entitled to from the Company.

 

		6.5.	The Company shall provide the Employee, for the purpose of fulfilling his Office, a cellular phone.
The Employee will be entitled to use the cellular phone for work purposes and within his Office as well as for reasonable private
use. The Company shall bear all of the fixed and current expenses incurred in respect of the cellular phone. Tax in respect of
the use value which will apply shall be deducted from the Employee's Monthly Salary according to law.

 

    	8

    	 

    

 

		7.	The Term of the Agreement

 

		7.1.	This Agreement is for an indefinite period of time, commencing on January 1, 2015 (the "Agreement
Term" and the "Office Commencement Date", respectively) and is subject to the following.

 

		7.2.	Each party may terminate this Agreement at any time and for any reason by providing an advance
written notice of ninety (90) days in advance.

 

		7.3.	The Company retains the right not to use the advance notice period, in whole or in part. The Company
may disconnect the employment relations with the Employee on any date prior to the expiration of the advance notice period as aforesaid,
and pay the Employee redemption of compensation in respect of the part of the advance notice period during which it waived the
employment of the Employee; the redemption will be done based on the Salary and the Company's contributions and the Employee's
right for social and related benefits, other benefits as specified in Section 6 and exercise of the options to which the Employee
is entitled will not be prejudiced.

 

		7.4.	Throughout the entire Agreement Term, the Company shall be entitled to terminate the Agreement
immediately, with no advance notice, following a conclusive ruling by a court that one or more of the following events had occurred:

 

		7.4.1.	If the Employee shall be convicted in a criminal offense, except for traffic offenses and/or a
technical offense or one of strict liability.

 

		7.4.2.	If the Employee breached his fiduciary duty towards the Company and/or will not act and/or operate
with loyalty and/or credibly and/or honestly towards the Company.

 

		7.4.3.	The Company found out that the Employee's representations in Section 2 of this Agreement and/or
his undertakings, as specified in Section 3 above are untrue and/or inaccurate and/or are invalid;

 

		7.4.4.	The Company found out that he Employee had breached any of the provisions of Sections 9-10 below;

 

		7.4.5.	The Employee fundamentally breached the Agreement and did not remedy the breach, even though he
had received a 30 day notice or a shorter notice, according to the urgency of the matter and/or committed a severe disciplinary
offense in circumstances which entitle the employer to dismissal without severance pay.

 

    	9

    	 

    

 

		7.5.	The provisions of Section 7.4 above may not derogate from any remedy to which the Company will
be entitled by virtue of any law and/or agreement.

 

		7.6.	For the avoidance of doubt it is agreed, that in each of the events specified in paragraph 7.4
above, the dismissal shall enter effect immediately, without requiring the provision of an advance notice or payment in respect
thereof.

 

		7.7.	Upon the termination of the Employee's work at the Company for any reason, the Employee shall transfer
his Office in a full and orderly fashion to any person that the Company shall instruct him, and will deliver to the Company all
of the documents, information, equipment and material which he received as the Company's employee or that had been prepared by
him in respect to his work at the Company.

 

		8.	Options for Purchase of Shares

 

		8.1.	Subject to the resolution of the Company's board of directors and/or the committees thereof with
respect to Company options and benefits, in their sole discretion, and subject to the terms of the Company's option plan and the
option grant agreement which were approved and/or will be approved for this matter from time to time by the Company's board of
directors, in its sole discretion, which will include the conditions pertaining to the options, including the date and price of
exercise, the lock-up and release thereof and all of the other conditions and provisions pertaining to the options, the Employee
will be entitled to receive options for the purchase of shares under conditions, in amounts and on the dates specified in Annex
C to this Agreement.

 

		8.2.	Any tax liability pertaining to the options (including pertaining to the grant, exercise, sale
of the options or the underlying shares obtained upon the exercise thereof) will be exclusively imposed on the Employee, but the
Company shall adjust the option conditions to the provisions of the income tax laws, so that the Employee shall be able to postpone
the tax payment to the option exercise date.

 

		9.	Confidentiality

 

		9.1.	The Employee hereby undertakes to keep in confidence and not to disclose, show, deliver, whether
during his term of employment or thereafter, for indefinite time, to any person or body, in Israel or worldwide, trade, professional,
business and other secrets of the Company, or knowledge and/or information pertaining to the Company or related directly or indirectly
to the Company, its property, business and interests, its customers, suppliers, the persons or entities who were or are in contact
with the Company, including, but without derogating from the generality of the aforesaid – creation, concept, innovation,
copyright, patent, invention, design and any intellectual property right, improvement, idea, process, knowledge, conclusions, human
resources management and salary determination, terms of agreements in which the Company is engaged, and documents of the Company
– all whether the said secrets and/or knowledge and/or information reached him directly or indirectly, within his work and/or
during his work and/or in the process of his work and/or as a result of his employment and/or due to his Office and whether they
reached him directly or indirectly, in any other manner whatsoever. The Employee hereby confirms that the secrets and/or knowledge
and/or information as aforesaid are the Company's exclusive property and that he has no and will have no claims of any type whatsoever
in respect thereto or deriving therefrom.

 

    	10

    	 

    

 

		9.2.	The Employee hereby undertakes not to make use of any kind, in Israel and worldwide, of the secrets
and/or knowledge and/or information specified in Section 9.1 above, except if – and only to the extent such is necessary
– for the purpose of performing his Office at the Company. The Employee undertakes thereby not to utilize the said secrets
and/or knowledge and/or information in Israel and/or abroad, for his personal purposes and/or for his work in another workplace,
without limitation of time and place.

 

		10.	Intellectual Property

 

		10.1.	Without derogating from the undertaking annex attached to this Agreement, any confidential information,
including a creation, concept, innovation, improvement, idea, process, knowledge, conclusions, copyright, patent, invention, perfection,
design, development and any other intellectual property right and so forth – which had been developed or invented by the
Employee, alone or in cooperation with others, while or during or in relation to his work at the Company, will be the Company's
exclusive property, and the Employee will have no right of ownership and/or royalties and/or consideration and/or any other right
in respect of such information. Any implementation, analysis, commercialization, marketing, sale and/or any other use of such analysis
and/or invention, will be according to the Company's sole and absolute discretion. It shall be clarified that the consideration
paid to the Employee according to this Agreement includes also consideration for possible inventions which had been developed or
invented by the Employee, alone or in cooperation with others, within or during or following or in respect of his work at the Company
and the Employee will not be entitled to any additional or separate consideration in case of an invention which he had reached.

 

		10.2.	The Employee will be estopped and barred from making claims against the provisions of this Section
10, both claims resulting from the Israeli law and claims resulting from any foreign law, and will be prevented from approaching
any foreign tribunal and/or judicial and/or administrative instance. It is agreed that any dispute between the Employee and the
Company in respect of the provisions of this Section 10, including claims resulting from any foreign law, will be decided exclusively
by the competent courts at the Central District of Israel and only by them. Any dispute between the Employee and the Company will
be subject only to the Israeli law.

 

    	11

    	 

    

 

		10.3.	The provisions of this Section will apply also after the end of the term of this Agreement, for
any reason, or following the expiration of this Agreement, all with no limitation on time and place.

 

		11.	Remedies in the event of breach of the Confidentiality and Intellectual Property Provisions

 

		11.1.	The Employee agrees that the breach of the provisions of Sections 9 and/or 10 above will be deemed
as a fundamental breach of this Agreement and will deny the Employee of his right to payments from the Company, including: severance
pay and advance notice payment.

 

		11.2.	The Employee knows and understands that upon the breach of Sections 9 and/or 10 above by the Employee,
the Company shall petition to the court for an injunctive relief against the Employee and/or anyone on his behalf and/or against
any third party related to the Employee's acts and/or omissions, as well as with a monetary tort claim against them in respect
of the damage which will be caused to the Company, without derogating from any other remedy to which the Company will be entitled
by virtue of this Agreement and/or according to any law.

 

		11.3.	Without derogating from the aforesaid, the Employee irrevocably and conclusively waives any right
to the remedy of an injunction and/or mandatory injunction against the employer and any claim and/or demand of the Employee will
be solely for monetary remedy.

 

		12.	Exclusivity and Non-Competition

 

		12.1.	Without derogating from the provisions of Annex A attached hereto, the Employee undertakes not
to engage with the Company's customers for 12 months from the date of termination of the term of employment for any reason whatsoever,
unless he had received the Company's advance written consent therefor.

 

		12.2.	The Employee undertakes not to engage, work, participate and/or consult, directly or indirectly,
whether himself or through others, whether as a hired employee, independent or freelancer, or in any other manner, in a business,
position, work or any other occupation which competes and/or might compete with the Company's business, both during the term of
employment as defined above and during a period of additional 12 months from the date of termination of the term of employment
for any reason whatsoever, unless he had received the Company's advance written consent therefor.

 

    	12

    	 

    

 

		13.	Miscellaneous

 

		13.1.	It is agreed that the provisions of this Agreement exhaust the agreements between the parties,
and any promise, undertaking, consent, memorandum of understanding, representation made between the parties, if made prior to the
execution hereof, whether in writing or orally, are hereby null and void, and have no evidential use against the Company.

 

		13.2.	Any change in the terms and provisions of this Agreement requires another written document which
will be executed by the parties to this Agreement.

 

		13.3.	The parties agree that sole and exclusive jurisdiction on all matters relating to the rights deriving
from and/or related to this Agreement, shall lie with the competent courts and/or tribunals in the Central District.

 

		13.4.	In the event that any provision or provisions of this Agreement shall be ruled unenforceable or
completely invalid, such will not affect or prejudice the legality, validity and enforceability of the remaining provisions of
the Agreement which are not related to and/or deriving from the invalid obligation.

 

		13.5.	Any delay in the enforcement proceedings of any right according to this Agreement and according
to any law will not be deemed as a waiver of such right or any other right and will not prevent the possibility of claiming remedies
due to the breach of the right, including the enforcement thereof at a later date.

 

		13.6.	The parties undertake to fulfill all of their undertakings in this Agreement with loyalty, in good
faith and based on trust relations.

 

		13.7.	The parties' addresses are as specified in the preamble to this Agreement. Any notice provided
by one party to the other, will be deemed as having been received within 3 business days from the date of dispatch thereof by registered
mail, or upon its delivery by a courier, whichever is earlier.

 

		13.8.	The engagement in this Agreement including the annexes hereto is subject to the receipt of approval
of the competent organs at the Company.

 

In witness whereof, the parties have hereto
set their hands:

 

	/s/ Zeev
    Weiss 	 	/s/ Oren Mohar
	The Company	 	The Employee

 

    	13

    	 

    

 

Annex A

 

Letter of Undertaking for confidentiality/non
competition/endorsement of intellectual property rights

 

Made and executed on December 31,
2014

 

Between Oren Mohar  I.D.
028051282 (the “Employee”)

 

and Intec Pharma Ltd. Company Number
513022780 from Jerusalem, 12 Hartom st. (the “Company”)

 

		1.	Confidentiality

 

Without derogating from the definition
of “Confidential Information” in the employment agreement to which this Letter of Undertaking for Confidentiality/Non
Competition/Endorsement of Intellectual Property Rights (“This Agreement”) is an annex (the “Employment
Agreement”), “Confidential Information” includes research and development pertaining to existing or
future products, inventions, hardware, computer software, databases, chart, technique, drawing, idea, process, manufacturing method,
formula, procedure, business plan, clients, financial information, marketing plans and any trade secret (whether patentable or
not), improvements and knowledge pertaining to the aforesaid, and any information or data related or pertaining to the technology,
products or services of the Company or of companies affiliated thereto (existing, potential or future), or pertaining to the business
of the Company or of companies affiliated thereto (existing, potential or future) in any other manner, including any business information
pertaining to clients and suppliers, whether tangible or not, and any other trade secret, as defined in the Law of Commercial Torts,
5759-1999, of the Company or of a company affiliated thereto. The aforesaid will not apply to information which had been made public
domain by the Company or in any other legal manner.

 

		1.1.	The Employee shall maintain the confidentiality and secrecy of any Confidential Information as
defined above, which had reached the Employee’s knowledge during the provision of the services or the engagement with the
Company or an affiliated company thereof or as a result therefrom, and the Employee will not disclose, use, publish or otherwise
expose, directly or indirectly, Confidential Information as aforesaid at any time during or after the expiration of the term of
his employment by the Company, with no limitation of time and place, without the explicit approval of a competent representative
of the Company in advance and in writing.

 

    	14

    	 

    

 

		1.2.	Any Confidential Information, whether it is in written material, documents, computer software and/or
hardware, electronic media, magnetic media, servers or in any other form or manner (all hereinafter: the “Documents”)
including notebooks, notes, memos, records, diagrams, drawings, bulletins, formulas, reports, computer programs, other information
of any type whatsoever which reached the Employee’s possession or which was prepared by the Employee or by others, is the
Company’s or an affiliated company’s exclusive property, as the case may be. The Employee hereby undertakes to return
to the Company Documents as aforesaid or any other material which belongs to the Company that is in his possession (a) if he was
requested to do so by the Company or (b) upon the termination of the Employee’s employment by the Company, whichever is earlier,
and if he was requested to do so by the Company, to sign a written statement in which he will confirm that he has carried out the
aforesaid.

 

		1.3.	It is clear and understood by the Employee that all of the confidential information is material
business information which is the property of the Company or of companies affiliated thereto, or of third parties to whom the Company
or the affiliated companies thereto have a duty of confidentially, which is not public domain and which may not easily be discovered
by others, whose confidentiality provides the Company or affiliated companies thereof, a commercial advantage over their competitors,
and that the Company takes reasonable measures to maintain the confidentiality thereof.

 

		1.4.	The Employee’s undertakings according to this Agreement are towards the Company and any parent
company, subsidiaries, affiliated companies and anyone which shall replace it according to law, as in effect from time to time.

 

		1.5.	The Employee’s undertakings pursuant to this Section, will remain in effect after termination
of the Employee’s employment, according to the Employment Agreement.

 

		2.	Non Competition

 

		2.1.	The Employee agrees that during the term of the Employment Agreement and for twelve months following
termination thereof, for any reason whatsoever, he will not engage, be involved or affiliated in any manner, or employed, directly
or indirectly, alone or together with others, for himself or as an agent, broker, manager, licensor, employee, officer, director,
partner, member of a joint venture, shareholder, investor, consultant or otherwise, and without the Company’s prior written
notice, in any business or venture, anywhere in the world, which engages in any activity within which (a) there are products or
services which compete with products or services of the Company, or with products or services of the Company’s affiliated
companies pertaining to the Company’s business, as they were upon the termination of the Employees’ employment (b)
there are information, processes, technology or equipment in which the Company has a proprietary right, or in which a company affiliated
to the Company has a proprietary right, and which are related to the Company’s business which exist currently or will exist
in the future, or which are based on technology similar to that which was developed by the Company. The aforesaid will not apply
to (a) holding securities in any company whose shares are traded in public on the stock exchange which received international acknowledgement,
provided that such holding will not exceed 1% of the issued share capital of a public company as aforesaid, and the Employee does
not fulfill an active office in a public company as aforesaid as a director, employee, consultant (including independent consultant)
or any other active position, or (b) non-commercial activities which constitute de minimis.

 

    	15

    	 

    

 

		2.2.	The Employee agrees, that for the period of the Employee’s employment by the Company and
for a period of 24 months from the date of termination of his employment, for any reason whatsoever, the Employee will not solicit
or encourage, directly or indirectly, himself or within a business in which the Employee is an employee, officer, director, shareholder,
consultant or contractor, for any purpose and at any place, a person who was employed by the Company or an affiliated company thereof,
to terminate their employment with the Company or a company affiliated thereto, as the case may be.

 

		2.3.	The Employee agrees that for two years from the date of termination of engagement in the Employment
Agreement, he will not employ, directly or indirectly, a person who was employed by the Company or a company affiliated thereto,
during the two years which preceded the engagement termination date, as aforesaid.

 

		3.	Endorsement of Intellectual Property Rights

 

		3.1.	For the purposes of this Annex, the following definitions shall apply:

 

“Inventions”
mean, inter alia, any invention, discovery, idea, improvement, change, betterment, document, software, hardware, firmware,
creation, form, mask works, work, chart, original creation, formulas, techniques, methods, systems, processes, compositions of
material, databases, knowledge, information and trade secrets, which were created, invented, discovered, developed, composed or
processed by the Employee during his employment or twelve (12) months thereafter (or the maximal period permitted by law if its
shorter), in whole or in part, or that the Employee’s efforts contributed to the creation thereof, independently or in cooperation
with others, whether patentable or protectable by virtue of copyrights or another protection or not, and:

 

		(a)	Which are related, directly or indirectly to the Company’s business, as defined in the Employment
Agreement, including a platform for gastric drug retention or which were created while using the Company’s equipment; or

 

		(b)	Which are related to existing research and development or in respect of which it can be proven
that they are being planned, pertaining to the Company’s business, or research and development as aforesaid of the Company’s
affiliated company; or

 

    	16

    	 

    

 

		(c)	Which are developed, in whole or in part, during the Company’s working hours, or by using
equipment, supply, facilities or confidential information of the Company or of a company affiliated thereto.

 

“Trade Secrets”
mean “trade secrets” as defined in the Law of Commercial Torts, 5759-1999, and any record, software, hardware, form,
client list, knowledge and information of any type or nature, pertaining to the Company’s business, in the past, present
or future, or any plans in respect thereof, or pertaining to the business of a third party, in the past, present or future, or
to any plans in respect thereof (including any object or information in any form whatsoever in respect of which it had been provided
in law that is a trade secret) which reached the Employee’s knowledge, which the Company does not disclose to third parties
with no restrictions on use or restrictions on the disclosure to other third parties.

 

		3.2.	Without derogating from any other provision of law:

 

		a.	The Employee will put into writing, and will expose before the Company or a company affiliated
thereto, together with explanations, any invention and will conduct accurate records regarding the contemplation of any invention
and implementation of the idea. Such records will be the Company’s exclusive property, and the Employee will deliver possession
in the records to the Company, upon the termination of his engagement with the Company.

 

		b.	The Employee hereby assigns to the Company or to the affiliated companies thereof, with no additional
consideration to the Employee, the full and exclusive rights, ownership, possession and title in the Inventions, and in all of
the proprietary and intellectual property rights therein, and in the proprietary and intellectual property rights deriving therefrom
or based thereon, both in Israel and abroad. The Employee will sign any assignment, statement or other document which will be prepared
by the Company for giving effect to the aforesaid. The Employee hereby confirms and will confirm in the future the exclusive intellectual
property rights of the Company and of affiliated companies thereof, in Israel and abroad, in all of the Inventions.

 

		c.	During the Employment Agreement term and thereafter, the Employee shall provide the Company with
any reasonable information, document and assistance which the Company shall require in order to prepare, perform and complete the
registration of the proprietary rights, intellectual property and his patent in the Inventions and the trade secrets and the rights
as aforesaid deriving from the invention and in the trade secrets or which are based thereon, to protect them or enforce them,
in any jurisdiction according to the Company’s discretion. The Company, according to its sole discretion, will determine
the scope of the rights as aforesaid in the inventions and trade secrets or deriving therefrom, if there shall be such, which must
be protected. Such assistance includes the preparation of documents, drawings and other data, and the signing of right assignment
documents, applications and other forms. Any such information, document and assistance will be provided to the Company by the Employee
with no additional cost for the Company, except for out-of-pocket cash expenses actually incurred by the Employee upon the Company’s
request.

 

    	17

    	 

    

 

		d.	During the Employment Agreement term and thereafter, the Employee will maintain the secrecy and
confidentiality of the Inventions as if they were Confidential Information pursuant to this Agreement, will not expose them to
others without obtaining prior written permission from the Company and will not use such Inventions for any purpose whatsoever,
except for the purpose of performance of services for the Company.

 

		4.	Remedies

 

It is clear to and understood by the Employee
that the breach of the undertakings included in this Agreement or any part thereof, shall cause the Company or affiliated companies
thereof severe and irreversible damage. In view of the aforesaid, the Employee agrees that in case of such breach or anticipated
breach, the Company, the Company’s affiliated company or anyone to whom the Company or an affiliated company thereof had
assigned their rights to, will be entitled, without prejudice to any rights, and in addition to other rights, remedies and compensation
available thereto by law or equity, to a preliminary or perpetual injunction, or any other possible equitable remedy, in order
to prevent or remove the breach or the attempted breach of this Agreement by the Employee or by any person or entity acting for
him or on his behalf. In case that proceedings had been initiated for enforcement of the terms of the restrictions in the Agreement
as aforesaid, the lawfully winning party will be entitled, in addition to any other remedy, to the restitution of any reasonable
amount in respect of legal fees and other expenses which were involved in the measures initiated, both in the trial court and in
the court of appeals, and in any bankruptcy proceeding. In case that a competent court shall decide in a final decision that is
no longer appealable, that the scope, duration of time or geographic boundaries specifically determined in any of the restrictions
set forth in the Agreement are too extensive for enforceability, the said court will be authorized, and the parties to this Agreement
agree and determine hereby, that such court will amend the terms of the restrictions as aforesaid and will enforce the terms according
to the scope, duration of time and geographic boundaries which it will deem just and appropriate, while taking the parties’
intention into account.

 

		5.	Confirmations and Representations

 

The Employee hereby
represents and confirms the following:

 

		5.1.	The Employee’s undertakings for non competition and confidentiality according to this Agreement
are fair, reasonable and proportionate and were intended to protect secrets and confidential information of the Company and affiliated
companies thereof, which are the essence of the Company’s protectable business and commercial advantages in which significant
capital has been invested.

 

    	18

    	 

    

 

		5.2.	Breach of his aforesaid undertakings – will be contrary to the special fiduciary and loyalty
relations between the parties as employee and employer, to proper commerce practices, and to the duty of good faith and fairness
between the parties, it will prejudice the Company’s business, and will constitute a fundamental breach of This Agreement
and of the Employment Agreement.

 

		5.3.	It is clear to and understood by the Employee, that the limited time period and the geographic
area as specified in this Agreement are reasonable in view of the nature of the Company’s business and the knowledge of the
Employee pertaining to the Company’s business.

 

		5.4.	The Employee represents that his undertakings pursuant to this Section, which are reasonable and
proportionate – do not prevent him from developing the general knowledge and professional expertise in the field of his occupation,
in respect to parties who are not customers or employees of the Company, and without stealing the Company’s secrets.

 

		5.5.	The Company will be entitled to assign the undertakings of the Employee thereto in this Agreement.
The Employee will not be entitled to assign or to transfer to another his duties pursuant to this Agreement without the Company’s
prior written approval. This Agreement binds the Employee’s heirs, permitted assignees and anyone who shall come in his lieu
according to law.

 

	/s/ Oren Mohar	 	/s/ Zeev Weiss
	 	 	 
	The Employee	 	Intec Pharma Ltd.

 

    	19

    	 

    

 

Annex B 

 

General Approval (Combined Version) Regarding
Employers’ Contributions to 

Pension Funds and
Insurance Funds in lieu of Severance Pay

Under the Severance Pay Law, 5723-1963

[Updated as of February 28, 2001]

 

By virtue of my power under Section 14
of the Severance Pay Law, 5723-19631 (the “Law”), I hereby confirm, that contributions made by an employer
for his employee, commencing as of the date of publication of this approval, to a comprehensive pension in a provident fund for
annuity that is not an insurance fund within the meaning of such term in the Income Tax Regulations (Rules for the Approval and
Management of Provident Funds), 5724-19642 (a “Pension Fund”) or to a managers’ insurance that includes
the possibility of an annuity or a combination of payments to an annuity plan and to a non-annuity plan within such insurance fund
(an “Insurance Fund), including combined contributions made by the employer to a Pension Fund and to an Insurance Fund, whether
or not the Insurance Fund includes an annuity plan (the “Employer's Contributions”), shall be payable in lieu of severance
pay due to such employee in respect of the salary from which such contributions were made and the period they were made for (the
“Exempt Salary”); provided, however, that all of the following conditions have been fulfilled:

 

		(1)	The Employer's Contributions -

 

		(a)	To the Pension Fund, are at a rate of no less than 14 1/3% of the Exempt Salary, or 12% of the
Exempt Salary, if in addition thereto, the employer makes supplementary severance pay contributions for his employee to a provident
fund for severance pay or to an Insurance Fund in the employee's name, at a rate of 2 1/3% of the Exempt Salary. In the event that
the employer has not contributed such 2 1/3% in addition to said 12%, his contributions shall only replace 72% of the employee's
severance pay;

 

		(b)	To the Insurance Fund are at a rate of no less than one of the following:

 

		(1)	13 1/3% of the Exempt Salary, if in addition thereto, the employer makes contributions for his
employee for securing monthly income in the event of disability to a plan approved by the Commissioner of the Capital Market, Insurance
and Savings at the Ministry of Finance, at the rate required to secure at least 75% of the Exempt Salary or a rate of 2 1/2% of
the Exempt Salary, whichever is lower (“Disability Insurance Contributions”); or

 

 

		1	Statues 5723, p. 136.

		2	Regulations 5724, p. 1302.

 

    	20

    	 

    

 

		(2)	11% of the Exempt Salary, if the employer also made Disability Insurance Contributions, and in
such case the Employer's Contributions shall only replace 72% of the Employee's severance pay; In the event that the employer has
made, in addition to the foregoing, supplementary severance pay contributions to a provident fund for severance pay or to an Insurance
Fund in the employee's name at a rate of 2 1/3% of the Exempt Salary, the Employer's Contributions shall replace 100% of the employee's
severance pay.

 

		(2)	By no later than three months of the commencement date of the Employer's Contributions, a written
agreement is executed between the employer and the employee that includes:

 

		(a)	The employee’s consent to the arrangement pursuant to this approval in a form specifying
the Employer's Contributions, and the Pension Fund and Insurance Fund, as applicable; such agreement shall also include the form
of this approval;

 

		(b)3	The employer’s advance waiver of any right he may
have to a refund of monies from his contributions, unless the employee’s right to severance pay has been revoked by virtue
of Sections 16 or 17 of the Law, and to the extent so revoked, or the employee has withdrawn monies from the Pension Fund or Insurance
Fund other than by reason of an Entitling Event; in such regard "Entitling Event" means death, disability or retirement
at or after the age of 60 or more

 

		(c)	This approval shall not derogate from the employee's right to severance pay under any law, collective
agreement, expansion order or employment contract, in respect of salary over and above the Exempt Salary.

 

	 	Eliyahu Yishai
	 	 
	 	Minister of Labor and Social 

Affairs

 

Signature of employee:

 

	 	 	 	 	[signature]	 
	 	 	 	 	 	 
	Date:	 	 	Signature:	/s/ Oren Mohar	 

 

 

		3	Amendment: Official Gazette 4803, 5760 (September 19, 1999).

 

    	21

    	 

    

 

Annex C

 

Allocation of options to an Employee pursuant
to Section 8.1 of an Employment Agreement

 

Entered into and executed on December
31, 2014

 

Between Oren Mohar I.D.28051282 (the
"Employee")

 

and Intec Pharma Ltd. Public Company 513022780
of Jerusalem, 12 Hartom St. (the "Company")

according to an employment agreement dated December
31, 2014

(the "Employment Agreement")

 

		1.	The Options Granted:

 

The Employee will be granted 3,000,000
options of the Company, pursuant to the provisions of the Company's option plan for Employees, officers, directors and consultants
from 2005 (the "Option Plan") which will be vested as follows:

 

		1.1.	1,000,000 options for the purchase of 1,000,000 shares of the Company of NIS 0.01 par value each
("Ordinary Shares"), which will vest over 4 years, 50% of the time based options will vest upon the expiration
of two years following the date of allocation thereof and the remaining 50% will vest in portions of 6.25% in the end of each quarter
during two additional years, and will be exercisable against the exercise price which will be equal to the average price of the
Company's share on TASE during the thirty trading days which preceded the date of approval of the decision by the Company's board
of directors.

 

		1.2.	600,000 options, which will be fully vested immediately following the taking effect of a material
agreement, as defined in the Company's compensation policy, and will be exercisable against the exercise price as specified in
Section 1.1. above.

 

		1.3.	1,400,000 options for the purchase of Ordinary Shares of the Company against the exercise price,
as specified in this Section below, whose vesting is contingent upon the Company's carrying out an issuance overseas during his
term of employment:

 

		I.	The options in respect of such overseas issuance will be fully vested immediately upon the completion
of the issuance process, namely the receipt of the proceeds from the issuance and the entrance thereof into the Company's account,
but no earlier than upon the expiration of 1 month from the Employee's Office Commencement Date as defined in the Employment Agreement.
The options in respect of an overseas issuance will remain in effect for a period of up to 72 calendar months from the date of
grant thereof.

 

    	22

    	 

    

 

		II.	In the event that within 18 months from the Employee's Office Commencement Date (as defined in
the Employment Agreement), the Company shall not carry out an issuance overseas, but will execute a material agreement, 400,000
options out of the 1,400,000 options as specified in Section 1.3 above will be vested, in addition to the 600,000 contingent options
as specified in Section 1.2 above.

 

		III.	In the event that the Company shall carry out an issuance overseas, after execution of a material
agreement as specified in Subsection II above, after the expiration of 18 months from the Employee's Office Commencement Date (as
defined in the Employment Agreement), the Employee will be entitled to exercise the 1,000,000 options remaining out of the 1,400,000
as specified in Section 1.3 above.

 

The exercise price regarding the 1,400,000
options specified in Section 1.3 will be as follows:

 

		I.	The exercise price will be equal to the average price of the Company's share on TASE during the
thirty trading days preceding the date of approval of the decision regarding the allocation by the Company's board of directors,
as specified in Section 1.1. above.

 

		II.	Subject to the obtainment of all of the required approvals, including the approval of the tax authorities,
if and to the extent necessary, in the event that the Company shall execute a material agreement, prior to the performance of an
issuance overseas, the exercise price will be the higher of the thirty day average of the share price on TASE preceding the Company's
board approval of the option allocation and the price equal to the average price of the Company's share on TASE during the thirty
trading days following the execution date of a material agreement. In the absence of such transaction, the exercise price will
be equal to the average price of the Company's share on TASE during the thirty trading days preceding the date of approval of the
allocation resolution by the Company's board of directors, as specified in the previous Section.

 

The options shall expire upon the lapse
of 90 days from the Employee's engagement termination date, and will be deemed null and void and non-exercisable if until such
period the entitlement for exercise thereof has not yet arisen or that they had not been exercised by the Employee, all according
to the provisions of the Option Plan.

 

		2.	The Term of Entitlement

 

		2.1.	In the event of termination of the Employee's work, for any reason, which will apply during one
of the vesting dates, as specified above, the Employee will not be entitled to exercise the next portion.

 

    	23

    	 

    

 

		2.2.	Notwithstanding the aforesaid in Section 2.1 above, the Employee will be entitled to exercise the
next portion if there are 3 months remaining until the expiration of the vesting date of the current portion, including the advance
notice period.

 

		3.	The Exercise Date

 

		3.1.	The Employee will be entitled to exercise the Options, in whole or in part, at the exercise price,
at any time after the vesting date of the relevant portion, until the option Expiration Date, as defined in Section 3.2 below,
subject to the conditions for entitlement to options and the other provisions of this Annex.

 

		3.2.	The Employee will be entitled to exercise the options, subject to Section 3.1 above, until the
sixth year from the date of commencement of his employment at the Company, on 1st of January, 2015 (the "Expiration Date").

 

Options not exercised until the end
of this period, will be automatically nullified.

 

		3.3.	Notwithstanding the aforesaid, should the Employee's employment be terminated under the circumstances
specified in one of the events set forth in Section 7.4 of the Employment Agreement, the options shall expire, whether vested or
not, immediately upon the notice of termination of employment and will not be exercisable.

 

		4.	Option Plan

 

		4.1.	The options will be allocated according to the Plan which was filed to the Income Tax and will
be allocated through the capital track (with a trustee) of Section 102 of the Income Tax Ordinance (the said Section 102 and the
regulations and rules promulgated thereunder will be jointly referred to below as the "Provisions of Section 102").

 

		4.2.	According to the provisions of Section 102, options will be allocated to the trustee for the offeree
and the trustee will act with respect to the options and the underlying shares according to the Provisions of Section 102 and in
accordance with the trust provisions and option exercise and underlying shares sale procedure, as were specified and/or will be
specified between the Company and the trustee.

 

		4.3.	In order to ensure the performance of the tax laws, and in order to ensure the exhaustion of the
purchase rights proceedings according to the Plan, the options granted to the Employee will be held in trust by a trustee and the
trustee will act with regard to the options and the underlying shares according to the Provisions of Section 102 and in accordance
with the trust provisions and the option exercise and underlying shares sale procedures as were specified and/or will be specified
between the Company and the trustee. In the event that the Employee will elect not to receive or sell the shares upon the exercise
of the options, these shares shall also be held in the same trust.

 

    	24

    	 

    

 

		4.4.	According to the aforesaid, the Company will notify the trustee and any other entity require by
law, of the option allocation to the Employee according to the Agreement and the Annexes thereto. The Company has obtained all
of the approvals required by law, its incorporation documents and its Option Plan in order to grant options pursuant to this Annex.

 

		4.5.	Notwithstanding the aforesaid, the Company's Option Plan will apply to the Employee subject to
the modifications specified in the Agreement and Annexes thereto, and in any event that there are conditions in favor of the Employee
in the Agreement and the Annexes thereof compared to the Company's Option Plan, the provisions of the Agreement and the Annexes
thereto shall prevail, notwithstanding the provisions of the Company's Option Plan. It is agreed that it will not be possible to
prejudice or derogate from the Employee's rights or from the rights attached to the options or to the underlying shares thereof
without the Employee's consent.

 

		5.	Notice of Exercise

 

		5.1.	Exercise of the options will be done on one of the exercise dates through the provision of a written
notice (in the language attached as Annex C1 to the Employment Agreement), by the Employee to the Company, regarding his intention
to exercise the options which he is entitled to exercise until that date, in whole or in part and together with the exercise price
(the "Notice").

 

		5.2.	The Company will not allocate shares to the Employee prior to the completion of the full exercise
price of the options which the Employee seeks to exercise, as specified in this Annex and subject to the TASE directives.

 

		5.3.	The shares will be allocated to the Employee within 7 days from the date of provision of the notice.

 

		6.	No Transfer

 

		6.1.	The options may not be transferred, assigned, pledged etc., except by virtue of a will or the inheritance
law. The Employee's rights in the underlying shares are non-transferable unless according to the Option Plan.

 

		7.	Prevention or Restriction of Transactions in Options

 

		7.1.	The sale of the underlying shares will be subject to the lock-up rules, as applicable from time
to time, set forth in the TASE Rules and Regulations promulgated thereunder and/or in the Securities Law, 5728-1968, and the Regulations
promulgated thereunder, including the Securities Regulations (Details regarding Sections 15A to 15C of the Law), 5760-2000.

 

    	25

    	 

    

 

		7.2.	The options, the underlying shares and any (non-monetary) right in respect thereof will be locked-up
for a period of two years from the date of allocation of the options according to the Provisions of Section 102.

 

		8.	Taxation

 

		8.1.	Any tax liability related to the options, the exercise of the options into shares and/or regarding
their sale, will be exclusively imposed on the Employee, and in case of death, god forbid, on the heirs, without the Company bearing
such directly and/or indirectly. The tax which will apply will be deducted on the liability date from the proceeds of the sale
by the trustee or by the Company, as applicable. The tax liability of the Employee (or the heirs, in case of death, god forbid),
will be set according to the Provisions of Section 102 of the Income Tax Ordinance and the tax rules or according to any other
law which will replace the same.

 

		9.	Miscellaneous

 

		9.1.	The options contemplated in this Annex are not negotiable and will not be listed for trading on
TASE. The Employee may not assign, pledge, mortgage or give any third party any right pertaining to the options or any of the option
portions.

 

		9.2.	It is clarified that the options granted pursuant to this Annex are not salary components for all
intents and purposes and the Company will not be obligated to perform in respect thereof any payment or contribution by law or
agreement (including payment of severance pay).

 

In witness whereof the parties have hereto
set their hands:

 

	/s/ Zeev
    Weiss	 	/s/ Oren Mohar
	The Company	 	The Employee

 

    	26

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00246-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00246-of-00352.parquet"}]]